Efficacy of patient-controlled intravenous analgesia combined hip capsule peripheral nerve block in total hip arthroplasty
Objective To investigate the effect of patient-controlled intravenous analgesia(PCIA)combined hip capsule peripheral nerve block in total hip arthroplasty(THA).Methods Fifty patients who underwent THA from January to August 2023 were enrolled and randomly assigned into control group(n=25)and observation group(n=25),All were given PCIA,and those in the observation group were additionally given hip capsule peripheral nerve block.The analgesic effect,postoperative inflammatory reaction,adverse events,and postoperative rehabilitation quality were compared between the two groups.Results The visual analogue scale(VAS)scores in resting and motion state at 24,36,48 hours postoperatively were significantly lower in the observation group than in the control group(P<0.05).The tumor necrosis factor alpha(TNF-α),interleukin-1 β(IL-1β),C-reactive protein(CRP)at 24 hours postoperatively decreased notably in the observation group compared with the control group(P<0.05).The incidence of adverse events in the observation group was significantly lower than that of the control group(4.00%vs 28.0%,P<0.05).The first out-of-bed activity time and hospitalization time were significantly shorter in the observation group relative to the control group(P<0.05).The Quality of Recovery-15(QoR-15)scale,Harris Hip Score(HHS)at 4 weeks postoperatively were significantly higher in the observation group than in the control group(P<0.05).Conclusion The PCIA combined hip capsule peripheral nerve block in THA patients can further improve analgesic effect,reduce adverse events and postoperative inflammation,and improve the postoperative rehabilitation quality.
patient-controlled intravenous analgesiahip capsule peripheraltotal hip arthroplastypainrehabilitation